Center for Veterinary Medicine
FDA Home Page | CVM Home Page | CVM A-Z Index | Contact CVM | Site Map

horizonal rule
Spacer FDA Logo links to FDA home page HHS Logo links to Department of Health and Human Services website U.S. Food and Drug Administration Center for Veterinary Medicine

CVM Update

<<Back

February 23, 2000

FDA RESCINDS HCG ENFORCEMENT DISCRETION GUIDANCE

In April 1998, FDA issued a level two guidance for industry (GFI) entitled, "Use of Human Chorionic Gonadotropin (HCG) as a Spawning Aid for Fish" (GFI #71.) This guidance stated that the Center for Veterinary Medicine (CVM) is not likely to object to the use of HCG as a spawning aid for fish if certain conditions are met.

CVM has determined that now it does object to the use of HCG products as a spawning aid for fish if such products have not been approved for that purpose. Therefore, GFI #71 is rescinded. Distribution and use of any HCG product as a spawning aid other than a product approved for that purpose would cause that HCG to be adulterated under section 501(a)(5) of the Federal Food, Drug, and Cosmetic Act. Extralabel use of a HCG product as a spawning aid is not permitted under the Animal Medicinal Drug Use Clarification Act (AMDUCA) because this is a production rather than a therapeutic use.

CVM notes that there is a new animal drug HCG approved for use as a spawning aid in fish (NADA 140-927.) That product, Chorulon Human Chorionic Gonadotropin, is sponsored and marketed by Intervet, Inc., Millsboro, DE.

Additional information on this subject is available from Frances Pell, Center for Veterinary Medicine, (HFV-235), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301-827-0188.


Issued by:
FDA, Center for Veterinary Medicine,
Office of Management and Communications, HFV-12
7519 Standish Place, Rockville, MD 20855
Telephone: (301) 827-3800 FAX: (301) 827-4065
Internet Web Site: http://www.fda.gov/cvm

Spacer
horizonal rule